(ARCAD) Arcadis - Ratings and Ratios

Exchange: AS • Country: Netherlands • Currency: EUR • Type: Common Stock • ISIN: NL0006237562

Architecture, Engineering, Consultancy, Asset Management, Environmental

Dividends

Dividend Yield 2.71%
Yield on Cost 5y 4.29%
Yield CAGR 5y 10.55%
Payout Consistency 94.5%
Payout Ratio 47.0%
Risk via 10d forecast
Volatility 25.2%
Value at Risk 5%th 36.9%
Relative Tail Risk -11.18%
Reward TTM
Sharpe Ratio -1.37
Alpha -46.54
CAGR/Max DD 0.03
Character TTM
Hurst Exponent 0.590
Beta 0.285
Beta Downside 0.368
Drawdowns 3y
Max DD 46.26%
Mean DD 13.10%
Median DD 6.77%

Description: ARCAD Arcadis November 07, 2025

Arcadis N.V. (AS: ARCAD) is a global design-, engineering-, architecture- and consultancy firm headquartered in Amsterdam, operating across the Americas, Europe, the Middle East and Asia-Pacific. It traces its roots to 1888 (originally Heidemij NV) and rebranded to Arcadis in 1997.

The business is organized into four operating segments-Places, Mobility, Resilience and Intelligence-delivering a broad portfolio that includes architectural and urban planning, asset-management strategy, lifecycle planning, risk assessment, and operational optimisation for built and natural assets. Its engineering footprint spans highways, railways, bridges, tunnels, power and water utilities, ports, geotechnics, and building MEP systems, while its digital suite covers environmental health & safety, sustainability analytics, and project-management platforms.

Key drivers for Arcadis include: (1) the global surge in infrastructure spending, with the World Bank projecting a $1.7 trillion annual increase in emerging-market road and rail investment through 2027; (2) a growing demand for ESG-linked services, reflected in Arcadis’ 2023 sustainability-related revenue growing 12 % YoY; and (3) its expanding digital-services pipeline, which contributed ~8 % of total revenue in 2023 and is expected to reach double-digit growth as clients adopt asset-intelligence tools. As of FY 2023, the company reported €3.2 bn of revenue, an order backlog of €1.4 bn (≈44 % of annual sales), and an adjusted EBIT margin of 6.5 %.

For a deeper quantitative view of Arcadis’ valuation metrics, scenario analysis, and peer comparison, the ValueRay platform offers a concise data-driven snapshot that can help you assess the stock’s risk-adjusted upside.

Piotroski VR‑10 (Strict, 0-10) 5.5

Net Income (160.0m TTM) > 0 and > 6% of Revenue (6% = 264.7m TTM)
FCFTA 0.07 (>2.0%) and ΔFCFTA 1.07pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 9.25% (prev 10.04%; Δ -0.79pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.08 (>3.0%) and CFO 308.7m > Net Income 160.0m (YES >=105%, WARN >=100%)
Net Debt (830.0m) to EBITDA (467.6m) ratio: 1.78 <= 3.0 (WARN <= 3.5)
Current Ratio 1.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (89.6m) change vs 12m ago NaN% (target <= -2.0% for YES)
Gross Margin 1.13% (prev -15.76%; Δ 16.89pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 112.6% (prev 75.81%; Δ 36.77pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 3.32 (EBITDA TTM 467.6m / Interest Expense TTM 85.8m) >= 6 (WARN >= 3)

Altman Z'' 2.34

(A) 0.11 = (Total Current Assets 1.93b - Total Current Liabilities 1.52b) / Total Assets 3.85b
(B) 0.25 = Retained Earnings (Balance) 946.0m / Total Assets 3.85b
(C) 0.07 = EBIT TTM 284.4m / Avg Total Assets 3.92b
(D) 0.34 = Book Value of Equity 946.0m / Total Liabilities 2.78b
Total Rating: 2.34 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 71.29

1. Piotroski 5.50pt
2. FCF Yield 6.83%
3. FCF Margin 6.29%
4. Debt/Equity 1.06
5. Debt/Ebitda 1.78
6. ROIC - WACC (= 4.55)%
7. RoE 14.17%
8. Rev. Trend 98.14%
9. EPS Trend -16.69%

What is the price of ARCAD shares?

As of December 07, 2025, the stock is trading at EUR 36.94 with a total of 154,530 shares traded.
Over the past week, the price has changed by -3.10%, over one month by -2.48%, over three months by -7.42% and over the past year by -40.43%.

Is ARCAD a buy, sell or hold?

Arcadis has no consensus analysts rating.

What are the forecasts/targets for the ARCAD price?

Issuer Target Up/Down from current
Wallstreet Target Price 57.4 55.5%
Analysts Target Price - -
ValueRay Target Price 34.2 -7.5%

ARCAD Fundamental Data Overview November 27, 2025

Market Cap USD = 3.77b (3.23b EUR * 1.1666 EUR.USD)
Market Cap EUR = 3.23b (3.23b EUR * 1.0 EUR.EUR)
P/E Trailing = 13.7962
P/E Forward = 10.5485
P/S = 0.6545
P/B = 2.9381
Beta = 0.655
Revenue TTM = 4.41b EUR
EBIT TTM = 284.4m EUR
EBITDA TTM = 467.6m EUR
Long Term Debt = 933.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 211.0m EUR (from shortLongTermDebt, last quarter)
Debt = 1.14b EUR (Calculated: Short Term 211.0m + Long Term 933.0m)
Net Debt = 830.0m EUR (from netDebt column, last quarter)
Enterprise Value = 4.06b EUR (3.23b + Debt 1.14b - CCE 314.0m)
Interest Coverage Ratio = 3.32 (Ebit TTM 284.4m / Interest Expense TTM 85.8m)
FCF Yield = 6.83% (FCF TTM 277.5m / Enterprise Value 4.06b)
FCF Margin = 6.29% (FCF TTM 277.5m / Revenue TTM 4.41b)
Net Margin = 3.63% (Net Income TTM 160.0m / Revenue TTM 4.41b)
Gross Margin = 1.13% ((Revenue TTM 4.41b - Cost of Revenue TTM 4.36b) / Revenue TTM)
Gross Margin QoQ = 12.60% (prev none%)
Tobins Q-Ratio = 1.05 (Enterprise Value 4.06b / Total Assets 3.85b)
Interest Expense / Debt = 4.59% (Interest Expense 52.5m / Debt 1.14b)
Taxrate = 20.72% (19.9m / 96.2m)
NOPAT = 225.5m (EBIT 284.4m * (1 - 20.72%))
Current Ratio = 1.27 (Total Current Assets 1.93b / Total Current Liabilities 1.52b)
Debt / Equity = 1.06 (Debt 1.14b / totalStockholderEquity, last quarter 1.08b)
Debt / EBITDA = 1.78 (Net Debt 830.0m / EBITDA 467.6m)
Debt / FCF = 2.99 (Net Debt 830.0m / FCF TTM 277.5m)
Total Stockholder Equity = 1.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.15% (Net Income 160.0m / Total Assets 3.85b)
RoE = 14.17% (Net Income TTM 160.0m / Total Stockholder Equity 1.13b)
RoCE = 13.79% (EBIT 284.4m / Capital Employed (Equity 1.13b + L.T.Debt 933.0m))
RoIC = 10.72% (NOPAT 225.5m / Invested Capital 2.10b)
WACC = 6.17% (E(3.23b)/V(4.37b) * Re(7.07%) + D(1.14b)/V(4.37b) * Rd(4.59%) * (1-Tc(0.21)))
Discount Rate = 7.07% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.54%
[DCF Debug] Terminal Value 75.71% ; FCFE base≈264.0m ; Y1≈224.9m ; Y5≈173.1m
Fair Price DCF = 35.91 (DCF Value 3.17b / Shares Outstanding 88.2m; 5y FCF grow -18.01% → 3.0% )
EPS Correlation: -16.69 | EPS CAGR: -52.85% | SUE: -2.29 | # QB: 0
Revenue Correlation: 98.14 | Revenue CAGR: 116.0% | SUE: 1.70 | # QB: 1
EPS next Year (2026-12-31): EPS=3.61 | Chg30d=-0.138 | Revisions Net=-2 | Growth EPS=+20.3% | Growth Revenue=+4.2%

Additional Sources for ARCAD Stock

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle